Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Plos One|January 13, 2018
Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIVN Chantal Peltenburg, Jörgen Bierau, Jaap A Bakker, et al.
Eclinicalmedicine|January 1, 2020
Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapyIngeborg E A Wijting, Ferdinand W N M Wit, Casper Rokx, et al.
Open Forum Infectious Diseases|April 3, 2024
Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort StudyMarta Vasylyev, Ferdinand W N M Wit, Carlijn C E Jordans, et al.
Plos Medicine|January 7, 2023
Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort studyKathryn S Hensley, Marlou J Jongkees, Daryl Geers, et al.
Plos Medicine|October 27, 2022
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort studyKathryn S Hensley, Marlou J Jongkees, Daryl Geers, et al.
Pageof 2